Literature DB >> 10483019

Relapsing catastrophic antiphospholipid antibody syndrome: a mimic for thrombotic thrombocytopenic purpura?

K C Cerveny1, A D Sawitzke.   

Abstract

SUMMARY: The catastrophic antiphospholipid antibody syndrome (CAPS) is an uncommon disorder characterized by widespread micro- and macrovascular changes due to intravascular thrombosis. This complication of the antiphospholipid antibody syndrome is often fatal and recurrences are very rare. The differential diagnosis of CAPS includes thrombotic thrombocytopenic purpura (TTP) and this distinction may be difficult, but essential, for appropriate therapy. Plasmapheresis is effective in both conditions, but anticoagulation, a mainstay in the treatment of CAPS, could be disastrous in TTP. We present the case of an elderly woman who survived two episodes of CAPS four years apart and whose clinical findings were also suggestive of TTP. The characteristics of TTP and CAPS are compared and the importance of accurate diagnosis is emphasized.

Entities:  

Mesh:

Year:  1999        PMID: 10483019     DOI: 10.1177/096120339900800613

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  7 in total

Review 1.  Renal involvement in antiphospholipid syndrome.

Authors:  Francisco Vileimar Andrade de Azevedo; Diego Germano Maia; Jozelio Freire de Carvalho; Carlos Ewerton Maia Rodrigues
Journal:  Rheumatol Int       Date:  2018-05-05       Impact factor: 2.631

Review 2.  Catastrophic antiphospholipid syndrome: treatment, prognosis, and the risk of relapse.

Authors:  Silvia Bucciarelli; Doruk Erkan; Gerard Espinosa; Ricard Cervera
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

3.  Recurrent episodes of hemorrhagic alveolitis in relapsing catastrophic antiphospholipid syndrome: the same side of the dark moon.

Authors:  Filippo Pieralli; Maddalena Grazzini; Vieri Vannucchi; Antonio Mancini; Daniele Cammelli; Carlo Nozzoli
Journal:  Clin Rheumatol       Date:  2013-12-21       Impact factor: 2.980

Review 4.  Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies.

Authors:  G Espinosa; S Bucciarelli; R Cervera; M Lozano; J-C Reverter; G de la Red; V Gil; M Ingelmo; J Font; R A Asherson
Journal:  Ann Rheum Dis       Date:  2004-06       Impact factor: 19.103

Review 5.  Antiphospholipid syndrome: an overview.

Authors:  John G Hanly
Journal:  CMAJ       Date:  2003-06-24       Impact factor: 8.262

Review 6.  The standard of care for immune thrombotic thrombocytopenic purpura today.

Authors:  X Long Zheng
Journal:  J Thromb Haemost       Date:  2021-06-30       Impact factor: 16.036

Review 7.  Renal Involvement in Antiphospholipid Syndrome.

Authors:  Alonso Turrent-Carriles; Juan Pablo Herrera-Félix; Mary-Carmen Amigo
Journal:  Front Immunol       Date:  2018-05-17       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.